pulmonologist known for his work in asthma epidemiology, genetics, genomics, and pharmacogenomics. Thus, our backgrounds are highly complementary, with our expertise further enhanced by our outstanding associate editors and editorial board.
Despite our diverse backgrounds, we share a common vision for Respiratory Research. Our first goal is to maintain the journal as the pre-eminent Open Access publication focused on advancing the understandings of lung health and disease, as established by our predecessors. We are committed to continuing to solicit and review a wide range of manuscripts spanning the breadth of respiratory medicine. We will augment this with efficient editorial review complemented by journalistic rigor and integrity. Second, we both agree that it is important to attract readership and investment by the young scientists of today, which are the stakeholders and senior authors of tomorrow. This emphasis on young readers can be further extended to early physician-scientists.
Next, we plan to begin a regular feature focusing on emerging technologies and their application to respiratory research and disease. These are areas of great evolving interest, but are currently under-represented in the Respiratory Research portfolio. Along a similar vein, we plan to actively pursue the opportunity to publish articles on emerging lung therapeutics, including early clinical trial results.
Finally, we remain very open and receptive to your feedback on the format and content of Respiratory Research and welcome your suggestions for future commentaries, reviews and other content. Please do not hesitate to contact either of us with your thoughts.
